Lung Cancer-Targeting Peptides with Multi-subtype Indication for Combinational Drug Delivery and Molecular Imaging

Written By Yiran Gan
Lung Cancer-Targeting Peptides with Multi-subtype Indication for Combinational Drug Delivery and Molecular Imaging - Chi et al. 2017

Lung Cancer-Targeting Peptides with Multi-subtype Indication for Combinational Drug Delivery and Molecular Imaging

Publication Date: 2017.11.21

Authors: Y. H. Chi, J. K. Hsiao, M. H. Lin, C. Chang, C. H. Lan and H. C. Wu

Journal: Theranostics 7(6):1612-1632 (2017)

DOI: 10.7150/thno.17573

Citation

Y. H. Chi, J. K. Hsiao, M. H. Lin, C. Chang, C. H. Lan and H. C. Wu, "Lung Cancer-Targeting Peptides with Multi-subtype Indication for Combinational Drug Delivery and Molecular Imaging", Theranostics 7(6):1612-1632. doi:10.7150/thno.17573 (2017).

Article Link

doi:10.7150/thno.17573

© 2017 Chi, Hsiao, Lin, Chang, Lan and Wu

Theranostics | Volume 7, Issue 6, Pages 1612-1632

Yiran Gan
Previous

Analytical performance of reagent for assaying tau protein in human plasma and feasibility study screening neurodegenerative diseases
Next

Development of a real time imaging-based guidance system of magnetic nanoparticles for targeted drug delivery